An invitation to open innovation in malaria drug discovery: 47 quality starting points from the TCAMS

ACS Medicinal Chemistry Letters

Volumn 2, Issue 10, 2011, Pages 741-746

  Calderón, Félix ^a   Barros, David ^a   Bueno, José María ^a   Coterón, José Miguel ^a   Fernández, Esther ^a   Gamo, Francisco Javier ^a   Lavandera, José Luís ^a   León, María Luisa ^a   MacDonald, Simon J F ^b,c   Mallo, Araceli ^a   Manzano, Pilar ^a   Porras, Esther ^a   Fiandor, José María ^a   Castro, Julia ^a  

^a GLAXOSMITHKLINE   (Spain)

^b Medicines for Malaria Venture MMV   (Switzerland)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

lead optimization; Malaria; open innovation; TCAMS

Indexed keywords

ANTIMALARIAL AGENT; TCMDC 123553; TCMDC 123580; TCMDC 123738; TCMDC 123794; TCMDC 123859; TCMDC 123870; TCMDC 124492; TCMDC 124514; TCMDC 124828; TCMDC 124833; TCMDC 125023; TCMDC 125114; TCMDC 125215; TCMDC 125225; TCMDC 125243; TCMDC 125317; TCMDC 125454; TCMDC 125473; TCMDC 125605; TCMDC 125643; TCMDC 131984; TCMDC 132459; TCMDC 132550; TCMDC 133193; TCMDC 133315; TCMDC 133427; TCMDC 134142; TCMDC 139046; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG POTENCY; DRUG QUALITY; DRUG STABILITY; IC 50; LIPOPHILICITY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 80054735856     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml200135p     Document Type: Article

References (17)

1. Greenwood, B. M.; Fidock, D. A.; Kyle, D. E.; Kappe, S. H. I.; Alonso, P. L.; Collins, F. H.; Duffy, P. E. Malaria: Progress, Perils and Prospects for Eradication J. Clin. Invest. 2008, 118, 1266-1276 (Pubitemid 351500419)
2. World Health Organization. World malaria report; http://www.who.int/ malaria/publications/atoz/9789241563901/en/index.htmlæ, 2009.
3. Anstey, N. M.; Russell, B.; Yeo, T. W.; Price, R. N. The Pathophysiology of vivax Malaria Trends Parasitol. 2009, 25, 220-227
4. WHO. Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000-2010; WHO Press: Geneva, Switzerland, 2010.
5. Nishtar, S. Public-Private "Partnerships" in Health-A Global Call to Action Health Res. Policy Syst. 2004, 2, 5
6. Leroy, D.; Doerig, C. Drugging the Plasmodium Kinome: The Benefits of Academia-Industry Synergy Trends Pharmacol. Sci. 2008, 29, 241-249
7. Lucumi, E.; Darling, C.; Jo, H.; Napper, A. D.; Chandramohanadas, R.; Fisher, N.; Shone, A. E.; Jing, H.; Ward, S. A.; Biagini, G. A.; DeGrado, W. F.; Dimond, S. L.; Greenbaum, D. C. Discovery of potent small molecule inhibitors of multi-drug resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay Antimicrob. Agents Chemother. 2010, 276, 128-134
8. Baragana, B.; McCarthy, O.; Sanchez, P.; Bosch-Navarrete, C.; Kaiser, M.; Brun, R.; Whittingham, J. L.; Roberts, S. M.; Zhou, X.-X.; Wilson, K. S.; Johansson, N. G.; Gonzalez-Pacanowska, D.; Gilbert, I. H. Beta-Branched acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase Bioorg. Med. Chem. Lett. 2011, 19, 2378-2391
9. Gardner, M. J.; Hall, N.; Fung, E.; White, O.; Berriman, M.; Hyman, R. W.; Carlton, J. M.; Pain, A.; Nelson, k. E.; Bowman, S.; Paulsen, I. T.; James, K.; Eisen, J. A.; Rutherford, K.; Salzberg, S. L.; Craig, A.; Kyes, S.; Chan, M -S.; Nene, V.; Shallom, S. J.; Suh, B.; Peterson, J.; Angiuoli, S.; Pertea, M.; Allen, J.; Selengut, J.; Haft, D.; Mather, M. W.; Vaidya, A. B.; Martin, D. M. A.; Fairlamb, A. H.; Fraunholz, M. J.; Roos, D. S.; Ralph, S. A.; McFadden, G. I.; Cummings, L. M.; Subramanian, G. M.; Mungall, C.; Venter, J. C.; Carucci, D. J.; Hoffman, S. L.; Newbold, C.; Davis, R. W.; Fraser, C. M.; Barrell, B. Genome Sequence of the Human Malaria Parasite Plasmodium falciparum Nature 2002, 419, 498-511
10. Guiguemde, W. A; Shelat, A. A.; Bouck, D.; Duffy, S.; Crowther, G. J.; Davis, P. H.; Smithson, D. C.; Connelly, M.; Clark, J.; Zhu, F.; Jimenez-Diaz, M. B.; Martinez, M. S.; Wilson, E. B.; Tripathi, A. K.; Gut, J.; Sharlow, E. R.; Bathurst, I.; Mazouni, F. E.; Fowble, J. W.; Forquer, I.; McGinley, P. L.; Castro, S.; Angulo-Barturen, I.; Ferrer, S.; Rosenthal, P. J.; DeRisi, J. L.; Sullivan, D. J.; Lazo, J. S.; Roos, D. S.; Riscoe, M. K.; Phillips, M. A.; Rathod, P. K.; Van Voorhis, W. C.; Avery, V. M.; Guy, R. K. Chemical genetics of Plasmodium falciparum Nature 2010, 465, 311-315
11. Plouffe, D.; Brinker, A.; McNamara, C.; Henson, K.; Kato, N.; Kuhen, K.; Nagle, A.; Adrian, F.; Matzen, J. T.; Anderson, P.; Nam, T. G.; Gray, N. S.; Chatterjee, A.; Janes, J.; Yan, S. F.; Trager, R.; Caldwell, J. S.; Schultz, P. G.; Zhou, Y.; Winzeler, E. A. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen Proc. Natl. Acad. Sci. 2008, 105, 9059-9064
12. Gamo, F. J.; Sanz, L. M.; Vidal, J.; de Cozar, C.; Alvarez, E.; Lavandera, J. L.; Vanderwall, D. E.; Green, D. V. S.; Kumar, V.; Hasan, S.; Brown, J. R.; Peishoff, C. E.; Cardon, L. R.; Garcia-Bustos, J. F. Thousands of Chemical Starting Points for Antimalarial Lead Identification Nature 2010, 465, 305-312
13. Wawer, M.; Bajorath, J. Extracting SAR information from a large collection of anti-malarial screening hits Large Collection of Anti-Malarial Screening Hits by NSG-SPT analysis Analysis ACS Med. Chem. Lett. 2011, 2, 201-206
14. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings Adv. Drug Delivery Rev. 1997, 23, 3-25 (Pubitemid 27046991)
15. Leeson, P. D.; Springthorpe, B. The Influence of Drug-Like Concepts on Decision-Making in Medicinal Chemistry Nature Rev. Drug Discovery 2007, 6, 881-890 (Pubitemid 350042396)
16. Daylight Chemical Information Systems, Inc. Daylight Theory Manual; www.daylight.com/dayhtml/doc/theory/index.html, 2008.
17. Bromidge, S. M.; Dabbs, S.; Davies, D. T.; Duckworth, D. M.; Forbes, I. T.; Ham, P.; Jones, G. E.; King, F. D.; Saunders, D. V.; Starr, S.; Thewlis, K. M.; Wyman, P. A.; Blaney, F. E.; Naylor, C. B.; Bailey, F.; Blackburn, T. P.; Holland, V.; Kennett, G. A.; Riley, G. J.; Wood, M. D. Novel and Selective 5-HT2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure-Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indulines J. Med. Chem. 1998, 41, 1598-1612 (Pubitemid 28221953)